Pipeline栓塞装置直径显著影响颅内动脉瘤治疗中被覆盖侧支的长期转归
回顾性分析137例患者148次Pipeline栓塞装置治疗,随访至少6个月常规血管造影,217条被覆盖侧支中29条(13.4%)闭塞、40条(18.4%)狭窄,均无症状;较小装置直径与分支闭塞相关,较小直径及术中阿昔单抗与分支狭窄/闭塞相关,前脉络膜分支类型为通畅预测因素。
要点
- Pipeline装置直径较小与随访中被覆盖侧支闭塞相关(全队列P=0.001,眼动脉亚组P=0.013)。
- 被覆盖侧支狭窄/闭塞均无症状,随访中无需特殊处理。
- 较小装置直径(P=0.029)和术中阿昔单抗(P=0.03)预测侧支狭窄/闭塞,前脉络膜分支类型(P=0.003)预测通畅。
核心结论
- 较小Pipeline栓塞装置直径与延迟性侧支狭窄/闭塞相关,可能因小口径装置金属密度更高;血流动力学因素(包括侧支循环潜力)仍为决定被覆盖侧支转归的首要因素,但分支开口处金属覆盖率也起重要作用。
研究设计与样本
- 回顾性研究,纳入本机构137例患者148次Pipeline栓塞装置治疗颅内动脉瘤,随访至少6个月常规血管造影,评估被覆盖侧支的长期通畅性并探索操作及解剖影响因素。
诊断标准与关键数值
- 217条被覆盖侧支中29条(13.4%)随访时闭塞,40条(18.4%)狭窄,所有狭窄和闭塞均无症状;全队列中较小装置直径与分支闭塞相关(P=0.001),眼动脉亚组中亦相关(P=0.013);狭窄与闭塞合并分析时,较小装置直径(P=0.029)和术中阿昔单抗给药(P=0.03)预测侧支狭窄/闭塞,前脉络膜分支类型(P=0.003)预测侧支明显通畅。
临床应用与阅片要点
- 阅片随访被覆盖侧支时,应关注装置直径较小及术中阿昔单抗给药者的侧支狭窄/闭塞风险,但原文报告所有狭窄和闭塞均无症状。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Although covered side branches typically remain patent acutely following Pipeline Embolization Device embolization of intracranial aneurysms, the long-term fate of these vessels remains uncertain. We therefore elected to investigate factors that may influence the long-term patency of these covered side branches.
MATERIALS AND METHODS: We retrospectively evaluated the long-term patency of side branches covered by the Pipeline Embolization Device at our institution during treatment of intracranial aneurysms with at least 6 months of conventional angiography follow-up. Procedural and anatomic factors that might influence the fate of covered side branches were explored.
RESULTS: One hundred forty-eight Pipeline Embolization Device treatments in 137 patients met the inclusion criteria. In 217 covered side branches, 29 (13.4%) were occluded on follow-up, and 40 (18.4%) were stenotic. All stenoses and occlusions were asymptomatic. In the entire cohort and in the largest subset of ophthalmic arteries, a smaller Pipeline Embolization Device diameter was associated with branch vessel occlusion (P = .001, P = .013). When we considered stenotic and occluded side branches together, smaller Pipeline Embolization Device size (P = .029) and administration of intraprocedural abciximab (P = .03) predicted side branch stenosis/occlusion, while anterior choroidal branch type (P = .003) was a predictor of gross side branch patency.
CONCLUSIONS: A smaller Pipeline Embolization Device diameter is associated with delayed side branch stenosis/occlusion following Pipeline Embolization Device treatment, likely due to the higher metal density of smaller caliber devices. Although hemodynamic factors, including the potential for collateral flow, are still paramount in determining the fate of covered side branches, the amount of metal coverage at the side branch orifice also plays an important role.
引用
- Miller TR, Kole MJ, Le EJ, et al. Pipeline Diameter Significantly Impacts the Long-Term Fate of Jailed Side Branches during Treatment of Intracranial Aneurysms. AJNR Am J Neuroradiol. 2018. PMID: 30385475. doi:10.3174/ajnr.A5863
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。